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Burkitt lymphoma (BL) is a malignant neoplasm of lymphoid tissue, affecting the B-lymphocytes.1 
It mostly affects children between 2 and 15 years of age and is known to affect more boys 
than girls in the ratio of 1.5:1.2 Burkitt lymphoma is a clinically aggressive and rapidly growing 
tumour with a reported tumour doubling time of less than 3 days.3 Burkitt lymphoma development 
has been linked to Epstein-Barr virus infection and malaria,4 and higher incidence rates have 
been reported amongst populations with higher burden of malaria, Epstein-Barr virus (EBV) and 
human immunodeficiency virus (HIV).5,6,7 The most common sites of presentation of the disease 
as seen in Cameroon include the following: abdomen (76%), face (50%), spleen (36%), liver (20%), 
kidney (18%), paraspinal (9%), bone marrow (9%), external lymph nodes (7%), chest wall (4%), 
cerebrospinal fluid (4%), cranial nerves (3%), femur (2%) and testis (2%).8 Diagnosis of BL is 
confirmed by histological and immunocytological demonstration of BL cells in tissue specimens.3 
Cytological examination of cerebrospinal fluid and bone marrow specimens is essential to 
ascertain metastasis and facilitate staging.8
Burkitt lymphoma makes up about 30%–50% of all childhood cancers recorded in tropical Africa.1,9 
Burkitt lymphoma treatment is available in a few treatment centres operating independently in 
different regions of Cameroon. A population-based cancer registry in the capital city Yaoundé 
reported an age-standardised incidence rate (ASIR) of 46.8 per million person years.10 Hospital-
based paediatric cancer registries exist in two centres in the North-West Region centres, including 
Banso and Mbingo Baptist Hospitals. Pathology laboratories also each keep a pathology-based 
cancer registry, including the pathology laboratories at Mezam Polyclinic Bamenda and Mbingo 
Baptist Hospital, both in the North-West Region.
Background: Burkitt lymphoma is one of the most common childhood cancers in Cameroon. 
Incidence rates of 5.9/100 000 and 2.58 per 100 000 have been reported in two studies in 2005 
and 2012 amongst children below 15 years in the North-West Region.
Aim: This study seeks to examine how Burkitt lymphoma incidence has varied between the 
various health districts of north-west Cameroon from 2003 to 2015.
Setting: North-West region of Cameroon.
Method: Ethics approval was obtained from the relevant university and Health Services 
Institutional Review Board. Population data was obtained from the regional delegation of 
public health. The Paediatric Oncology Networked Database registry from two hospitals and 
two pathology-based registries were reviewed for cases per year from the various districts. 
Age-standardised incidence rates were computed for all districts by year using the World 
Health Organizaion world standard populations.
Results: A total of 317 cases were registered. Overall age-standardised incidence rate was 3.07 
per 100 000. Annual incidence ranged from 0.09 in 2003 to 6.12 in 2010. The districts with the 
highest incidence rates for the entire study period include Nwa with 10.54; Ndop with 5.63; 
Benakuma with 5.48; Ako with 4.97; and Nkambe with 4.73.
Conclusion: Clustering of Burkitt lymphoma is seen in the region, with the highest incidence 
in Nwa, Ndop, Benakuma, Ako and Nkambe. These districts should be prioritised for awareness 
creation campaigns. There is need for a population-based childhood cancer registry in the 
region, which will use both active and passive surveillance methods to record all childhood 
cancer cases.
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Two earlier studies have described the epidemiology of BL 
in north-west Cameroon. Wright et al.11 reported an incidence 
of 5.9/100 000 in 2005, while Lewis et al.12 revealed an average 
incidence of 2.58 per 100 000 children under 15 years. As 
paediatric oncology care develops in the North-West Region 
of Cameroon, this study seeks to examine how the trends of 
BL incidence have varied between the various health districts 
of the region from 2003 to 2015, with the goal of identifying 
hot spots of the disease, which would be priority areas for 
awareness creation and early diagnosis initiatives.
Methods
This is a descriptive cross-sectional study. This study involved 
children under the age of 15 years living in the North-West 
Region of Cameroon between 2003 and 2015. Cameroon is 
classified by the World Bank as a lower middle income 
country in central Africa and holds a total population of 24 
million inhabitants, of which 43% are younger than 15 years.13 
The North-West Region of Cameroon has a total population 
of about 1 950 000 people14 divided into 19 health districts, 
namely Ako, Bafut, Bali, Bamenda, Batibo, Benakuma, 
Fundong, Kumbo East, Kumbo West, Mbengwi, Oku, Njikwa, 
Nkambe, Ndop, Ndu, Nwa, Santa, Tubah and Wum.15
The population data for the various years of the study was 
obtained from the regional delegation of public health. This 
is updated as per the 2007 national population census, and it 
is the population figures used for healthcare planning in the 
region. The population for the age group 0–14 years was 
calculated as 42.47% of the total population for each district, 
as suggested in the National Demographic Health Survey.16 
The World Health Organization (WHO) world standard 
populations were used to calculate ASIRs.17
Two hospital-based children’s cancer registries were reviewed 
for extraction of data for BL in the age group 0–14 years from 
2003 to 2015. These are the registries of Banso Baptist Hospital 
and Mbingo Baptist Hospital, all using the Paediatric Oncology 
Networked Database (POND) – an online paediatric cancer 
registration platform developed by St Jude’s Children’s 
Hospital in the USA.18 In these hospitals children clinically 
suspected of having BL are subjected to a fine needle tumour 
aspirate, bone marrow and cerebrospinal fluid cytopathology 
and an abdominal ultrasound to confirm the diagnosis. Two 
pathology-based registries in the region were also explored. 
Patient names and medical record numbers were cross-
checked to avoid duplication of cases during data extraction 
from the various registries.
Data analyses
Data extracted from the hospital-based and pathology 
registries included demographics (age, sex, district of 
residence), diagnosis information (disease name, method of 
diagnosis, date of diagnosis) and tumour site. Data were 
collected in Microsoft Excel 2016 and analysed using 
SPSS version 25. Calculations of ASIR using WHO standard 
populations were done by inserting formulas into the 
Excel spreadsheets. Means and standard deviations were 
used to describe continuous variables. Age-standardised 
incidence rates were computed for all districts by year.
Ethical considerations
This study used secondary data form. Ethics approval was 
obtained from the relevant Health Services Institutional 
Review Board (ethical clearance number: IRB2016-28). 
Permission was obtained from the administrators of all the 
health units and laboratories from which data were obtained.
Results
Clinical profile of cases
From 2003 to 2015, there were 317 registered children with BL 
in the North-West Region of Cameroon. A total of 279 cases 
were registered in the two hospital-based registries; while 38 
more were only recorded in the pathology-based registries. 
There were 136 (42.9%) females and 181 (57.1%) males, 
making a female:male ratio of 1:1.3. The age at diagnosis 
ranged from 1 to 14 years, with a mean of 8.02 years (standard 
deviation[SD] = 2.76).
Of all cases, 252 (79.5%) had cytological confirmation of BL 
while 57 (18%) were diagnosed only on a clinical basis, 
mostly with the use of ultrasound scan. One hundred and 
seventy one (54%) of the cases had only abdominal disease, 
95 (30%) had facial disease, while 45 (14%) had both 
abdominal and facial tumours.
Burkitt lymphoma distribution by year and 
district
The overall ASIR was 3.07 per 100 000 for children below 
15 years in the region in the study period from 2003 to 2015. 
Annual incidence ranged from 0.09 to 6.12. Age-standardised 
incidence rates generally increased over the study period, 
with a peak ASIR of 6.12 per 100 000 in 2010. From 2010 the 
BL incidence rate dropped steeply and has been fairly 
constant between 2.57 and 3.17 per 100 000 from 2013 to 2015 
(Figure 1).
The average ASIR in individual districts of the region for 
the entire study period ranged from 0/100 000 in Bali and 


























































FIGURE 1: Trend of age-standardised incidence for Burkitt lymphoma in the 
North-West Region, 2003–2015, for children aged 0–14 years.
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district (Table 1). Spatial clustering of BL cases was noticed 
within the region. The districts that recorded the highest 
incidence rates for the entire study period include Nwa with 
10.54/100 000; Ndop with 5.63 per 100 000; Benakuma 
with 5.48 per 100 000; Ako with 4.97 per 100 000; and Nkambe 
with 4.73 per 100 000. Despite fluctuations in ASIR over 
the years, with a remarkable drop from 2010, these districts 
consistently have higher incidence rates (Figure 2).
Discussion
The 317 patients included in this study were all the 
patients diagnosed and registered within the two pathology 
laboratories, two childhood cancer units in the North-West 
Region. It is likely that patients who travelled to other 
provinces for treatment were not recorded. The male 
predominance in Burkitt lymphoma amongst children under 
15 years has been reported in other population studies across 
Africa.4,5,19,20 The ratio of 1.3:1 in this study is the same as 
that reported by Lewis et al. in the North-West Region of 
Cameroon12 and not much lower than the ratio of 1.8 reported 
by Enow-Orock and colleagues in Yaoundé, Cameroon.21 
Pierce and Parker report a larger number of boys than girls 
for all childhood cancers put together.22 They suggest that 
this might be because of a prioritisation of the health of males 
over females amongst poor populations. The modal age 
group of 5–9 with mean of 8 years corresponds to expert 
suggestions and what has been reported in Yaoundé,21 and 
in other population studies.4,19
All the cytological diagnoses were done by use of fine needle 






































































































ASIR, age-standardised incidence rate.
FIGURE 2: Variation of Burkitt lymphoma incidence across health districts.
TABLE 1: Annual age-standardised incidence (0–15 years) of Burkitt lymphoma in various districts of the North-West Region, 2003–2015.
Health district 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Average
Ako - - - 0.00 8.63 0.00 0.00 11.52 16.82 6.31 0.00 5.39 6.00 4.97
Bafut 0.00 0.00 6.77 0.00 6.03 0.00 0.00 4.01 0.00 0.00 3.14 0.00 0.00 1.43
Bali 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Bamenda 0.00 0.96 1.81 0.00 4.76 1.06 2.74 1.82 0.71 2.37 0.00 0.68 0.57 1.25
Batibo 0.00 6.22 5.20 2.53 12.41 7.47 0.00 8.06 3.15 7.00 0.00 2.46 6.48 4.35
Benakuma - - - - - 13.90 12.79 0.00 4.63 3.80 0.00 0.00 14.79 4.86
Fundong 0.00 0.00 0.00 0.00 1.35 0.00 1.17 10.07 5.96 0.00 3.70 0.00 0.00 1.59
Kumbo West 1.31 0.00 5.81 2.98 3.24 5.34 8.67 1.42 0.00 0.00 0.00 0.00 0.00 2.06
Kumbo East 0.00 7.88 7.81 2.96 9.20 4.19 2.72 2.70 9.09 0.00 4.43 0.00 3.06 3.86
Mbengwi 0.00 0.00 3.51 0.00 2.45 0.00 2.77 0.00 0.00 0.00 0.00 8.62 4.25 1.54
Ndop 0.00 7.37 21.37 6.00 3.33 5.67 7.74 12.70 5.00 2.56 5.90 1.17 0.00 5.63
Ndu 0.00 0.00 8.53 1.38 2.19 2.13 0.00 17.52 6.59 0.00 26.38 0.00 3.14 4.85
Njikwa 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Nkambe 0.00 3.34 3.00 8.70 9.47 1.13 3.40 7.38 0.00 7.73 7.87 10.33 3.90 4.73
Nwa - - - - 0.00 17.30 23.89 17.48 4.31 13.83 2.81 15.13 10.65 10.54
Oku - - - - - - - - 0.00 0.00 1.38 0.00 2.66 0.67
Santa 0.00 0.00 0.00 2.43 2.03 0.00 0.00 3.61 0.00 0.00 0.00 0.00 3.35 0.82
Tubah - - - 4.69 4.55 12.28 0.00 7.30 0.00 0.00 4.55 0.00 0.00 3.03
Wum 0.00 0.00 6.48 3.11 0.00 0.00 8.83 0.00 2.03 0.00 0.00 0.00 0.00 1.46
Average 0.09 1.84 5.02 2.17 4.64 3.85 3.44 6.12 3.02 2.10 3.17 3.08 2.57 3.07
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cheap and fast23 and has been recommended for use in the 
diagnosis of BL in developing countries, where there is a 
limited number of surgeons and pathologists.24 In the absence 
of pathology, clinical diagnosis is accepted if the patient 
responds to BL treatment and if there is no contrary pathology 
diagnosis.24 Ultrasound scan has been shown to be helpful 
in the diagnosis of BL, by describing the nature of the 
tumours, which are typically hypoechoic.25 This is also useful 
for staging the disease.24
The dominance of abdominal involvement in this study 
supports what has been reported previously in Cameroon12,21,25 
and in Nigeria.19 Historically, facial presentation has been 
described as most common in BL in sub-Saharan Africa,26 but 
with advancement in imaging technology and increasing 
availability of ultrasound, early abdominal involvement is 
now detectable, which would otherwise be missed on clinical 
evaluation.25 As more developing countries use ultrasound 
as a routine clinical investigation for BL patients, there is 
increasing predominance of abdominal presentation of BL 
over facial presentation.27
The average BL incidence rate of 3.07/100 000 over the 
13-year period was a little higher than the rate of 2.58/100 000 
reported by Lewis et al. in the North-West Region of 
Cameroon12 but lower than the 4.68/100 000 reported from 
the Yaoundé Cancer Registry.10 The case ascertainment in 
this study and the study by Lewis and colleagues is likely to 
be less complete than that of Enow-Orock et al. because the 
data was extracted from hospital-based registries, while the 
Yaoundé Cancer Registry is a population-based registry, 
which is more complete in nature. Higher incidence rates 
have been reported elsewhere, with rates as high as 
8.4/100 000 children below 15 years in Ibadan, Nigeria.28 
Reported rates elsewhere in Africa include 2.15/100 000 
in Kenya14; 5.7/100 000 in Tanzania29; and 4.3/100 000 in 
Uganda.30
The drop in ASIR for the region from 2010 raises a question 
on whether there is a challenge with identifying and referring 
cases to the treatment centres or whether there is indeed a 
drop in the incidence rate of childhood cancer. One major 
issue surrounding childhood cancer care in Cameroon in 
general is the low level of community awareness about 
cancers in children and the availability of care.31 With the 
creation of the childhood cancer centre in the region in 2003 
at Banso Baptist Hospital, followed by another centre at 
Mbingo Baptist Hospital in 2006, childhood cancer care team 
members embarked on community sensitisation, leading to 
increased childhood cancer awareness in the region. This 
could arguably explain why BL diagnosis increased with a 
steep gradient between 2003 and 2005 and remained fairly 
high until 2010. However, the drop in registered number of 
BL patients below 15 years from 2010 despite continuous and 
intensified community sensitisation remains unexplained. 
A decline in BL incidence has been shown in Ibadan, Nigeria, 
a neighbouring country, by two different researchers, with 
incidence consistently decreasing with time.20,32 Babatunde 
et al. warn that the decreased number of registered BL cases 
might be because of economic crisis, as many children are 
left to die at home with disease without being brought to the 
hospital.20
We identified the districts with the highest incidence rates 
of BL to include Nwa, Ndop, Benakuma, Ako and Nkambe. 
Clustering, which refers to the concentration of cases in 
particular areas, in the region has been reported in the 
past.11,12 Previous studies highlight only the Ndop District as 
a cluster zone for BL in the region, with an incidence rate as 
high as 21.5 per 100 000 reported from 2003 to 200511 and 
10.3 per 100 000 for the period from 2003 to 2010,12 in contrast 
to this study, which found an incidence rate of 5.63 per 
100 000 in Ndop. This study did not investigate the disease 
stage for cases nor the delay from onset of disease to 
diagnosis, but Hesseling et al. report a predominance of late 
stage disease in this population with 72% Stage III and 12% 
Stage IV at diagnosis.8 This indicates a change in the high-
risk areas for BL in the region and calls for refocusing of 
awareness creation and early diagnosis trainings to the new 
areas of high incidence to ensure that all patients are promptly 
diagnosed and referred for treatment. Clustering was also 
noticed in western Kenya5 and has been reported to be 
associated to malaria endemicity.4,5,6,7 The two districts with 
the highest ASIR of BL are also the districts of highest malaria 
incidence in 2015.33 Investigating the association of BL with 
malaria in this region might provide some explanation 
for the observed clustering. Earlier studies in Kenya5,34 and 
Malawi7 have reported an association between BL and 
malaria incidence.
Limitations
Cancer registration in Cameroon is not well developed. Until 
now BL registration in north-west Cameroon has only been 
in the form of hospital-based childhood cancer registries and 
pathology-based cancer registries. It is purported that many 
children with cancer in developing countries like Cameroon 
go unrecorded for several reasons including paucity of cancer 
registries.35 In addition, there is the issue of non-identification 
of paediatric cancer patients, because of low paediatric cancer 
awareness in communities.31
Conclusion
This study has provided information about the trends in 
incidence rate of BL in children below 15 years between 
2003 and 2015. We have identified districts with high 
ASIR for BL, which should be targeted for awareness 
creation and early diagnosis trainings. The authors observe 
the possibility of incomplete case ascertainment in this 
study, which relied only on data from hospital-based 
and pathology registries. There is therefore need for a 
population-based childhood cancer registry in the region, 
which will use both active and passive surveillance methods 
to capture all the cases in the region. Further research is 
required to establish reasons why the ASIR is higher for 
some districts than others, as well as reasons for the drop in 
BL incidence in the region.
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